AI Bias Analysis
4 models · Takes ~15 seconds
Eli Lilly's deal with Profluent aims to go beyond CRISPR by using AI-designed enzymes to insert entire genes. It could reshape genetic medicine.
Source
Stat News
Opens original article in a new tab
New data on public trust in science, AI and mental health, and other news from Morning Rounds
“This could be the start of serious action on microplastics. Or it could end up as a headline with little behind it,” write Tim Ryan and Justin Zorn.
Google's clinical director Megan Bell Jones on how the company is addressing concerns over mental health impacts of its AI products.
“Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K. Manji, Eric J. Nestler, and Patrick J. Kennedy.
